# A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis

> **NCT00883623** · PHASE2 · COMPLETED · sponsor: **Heidelberg University** · enrollment: 50 (actual)

## Conditions studied

- Primary Amyloidosis

## Interventions

- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT00883623
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2013-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00883623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00883623, "A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) Amyloidosis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00883623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*